1. Adverse events with IL‐17 and IL‐23 inhibitors for psoriasis and psoriatic arthritis: a systematic review and meta‐analysis of phase III studies. (9th December 2019) Authors: Loft, N.D.; Vaengebjerg, S.; Halling, A.‐S.; Skov, L.; Egeberg, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 6(2020) Page Start: 1151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Concerns related to the coronavirus disease 2019 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey. (17th September 2020) Authors: Loft, N.D.; Halling, A.‐S.; Iversen, L.; Vestergaard, C.; Deleuran, M.; Rasmussen, M.K.; Zachariae, C.; Thyssen, J.P.; Skov, L. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 12(2020) Page Start: e773 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗